Skip to main content
SpringerLink
Log in

Costs of Insulin-Dependent Diabetes Mellitus

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Insulin-dependent diabetes mellitus (IDDM) is a prevalent chronic disease that causes marked personal and financial costs for patients, their families and society. Accurate information on costs of the disease is scarce. In this article, we review studies on disease and disease stage-connected costs at the individual and societal levels, and discuss possibilities of decreasing or preventing costs attributable to IDDM. The 3 disease stages are the initial treatment, follow-up after the initial treatment and late treatment.

Total costs of IDDM in a given country depend on the incidence of the disease and the efficiency (cost effectiveness) of treatment. Besides everyday treatment costs, the acute and long term complications of the disease cause major additional costs. The lifetime financial costs of IDDM and the amount of human suffering are always substantial.

The costs of the 3 clinical stages of IDDM differ markedly. The initial and late periods induce cost peaks, but the costs of follow-up after initial treatment are small. During initial treatment, costs depend mostly on the possible length of hospitalisation. During the late treatment period, costs begin to accumulate rapidly because of long term complications such as diabetic nephropathy, retinopathy, neuropathy and macro vascular disease.

Intensive ambulatory care, effective patient education that results in normoglycaemia or near-normoglycaemia in patients and, if needed, shortening of hospitalisations, are the only means to restrict or decrease the costs of IDDM until primary prevention is available. Postponing complications by any length of time will always decrease human suffering and lead to marked savings in healthcare resources.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Plotnick LP. Insulin-dependent diabetes mellitus. In: Oski FA, DeAngelis CD, Feigin RD, et al., editors. Principles and practice of pediatrics. Philadelphia: J.B. Lippincott, 1990: 1811–5

    Google Scholar 

  2. Sperling MA. Diabetes mellitus. In: Behrman RE, Vaughan III VC, editors. Nelson textbook of pediatrics. 13th ed. Philadelphia: Saunders, 1987: 1248–64

    Google Scholar 

  3. Lernmark Å, Morris PJ, Rubenstein AH. Preface. Diabetologia 1992; 35 Suppl. 2: A9–11

    Article  Google Scholar 

  4. Songer TJ. Health services and costing in diabetes. Med J Aust 1990; 152: 115–7

    PubMed  CAS  Google Scholar 

  5. Diabetes Epidemiology Research International Group (DERI). Geographic patterns of childhood insulin-dependent diabetes. Diabetes 1988; 37: 1113–9

    Article  Google Scholar 

  6. Tuomilehto J, Podar T, Reunanen A, et al. Comparison of incidenceof IDDM in childhood between Estonia and Finland, 1980–1988. Diabetes Care 1991; 14: 982–8

    Article  PubMed  CAS  Google Scholar 

  7. Goday A, Castell C, Tresserras R, et al. Incidence of type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain. Diabetologia 1992; 35: 267–71

    Article  PubMed  CAS  Google Scholar 

  8. Green A, Gale EAM, Patterson CC. Incidence of childhood-on-set insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 1992; 339: 905–9

    Article  PubMed  CAS  Google Scholar 

  9. Helgason T, Danielsen R, Thorsson AV. Incidence and prevalence of type 1 (insulin-dependent) diabetes mellitus in Icelandic children 1970–1989. Diabetologia 1992; 35: 880–3

    Article  PubMed  CAS  Google Scholar 

  10. Shubnikov E, Podar T, Tuomilehto J, et al. Low incidence of childhood IDDM in district of Novosibirsk (Russia). Diabetes Care 1992; 15: 915–7

    Article  PubMed  CAS  Google Scholar 

  11. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, et al. Epidemiology of childhood diabetes mellitus in Finland — background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 70–6

    Article  PubMed  CAS  Google Scholar 

  12. Karvonen M, Tuomilehto J, Libman I, et al. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 883–92

    Article  PubMed  CAS  Google Scholar 

  13. Stem Z, Levy R. The direct cost of type 1 diabetes mellitus in Israel. Diabet Med 1994; 11: 528–33

    Article  Google Scholar 

  14. Annex to Workprogramme on Biomedical and Health Research (1994–1998). European Union 1994; 8/11: 21

    Google Scholar 

  15. American Diabetes Association. Clinical practice recommendations. Screening for diabetes: position statement. Diabetes Care 1991; 14: 7–9

    Google Scholar 

  16. Direct and indirect costs of diabetes in the United States in 1992. Alexandria (VA): American Diabetes Association, 1993

  17. Diabetes outpatient education: the evidence of cost savings. Alexandria (VA): American Diabetes Association, Task Force on Financing Quality Health Care for Persons with Diabetes, 1992

  18. Reunanen A. Diabetes is a national disease [in Finnish]. Diabetes 1992 Aug: 9

  19. Jönsson B. Diabetes — the cost of illness and the cost of control. Acta Med Scand 1983; 671 Suppl.: 19–27

    Google Scholar 

  20. Kaplan RM, Davis WK. Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling. Diabetes Care 1986; 9: 81–6

    Article  PubMed  CAS  Google Scholar 

  21. Simell T, Simell O, Sintonen H. The first two years of type 1 diabetes in children: length of the initial hospital stay affects costs but not effectiveness of care. Diabet Med 1993; 10: 855–62

    Article  PubMed  CAS  Google Scholar 

  22. Kangas T. Ambulatory care, inpatient care and metabolic control of diabetic patients in Finland: research reports 29 [in Finnish]. Helsinki: STAKES (National Research and Development Centre for Welfare and Health), 1993

    Google Scholar 

  23. Kangas T, Sampo-Mäkinen T. Costs of diabetes for the society in Finland in 1989 [in Finnish]. Diabetes 1993 Dec: 29–33

  24. Kosonen K, Valkama N. Costs of diabetes to society in Finland in 1989: master thesis in Health Services Administration [in Finnish]. Kuopio (Finland): Department of Social Sciences, University of Kuopio, 1993

    Google Scholar 

  25. Bransome ED. Economics of diabetes and access to care: the United States perspective. In: Rifkin H, Colwell JA, Taylor SI, editors. Diabetes 1991 . Proceedings of the Fourteenth International Diabetes Federation Congress; 1991 Jun 23–28; Washington, DC. Amsterdam: Elsevier Science Publishers, 1991: 839–42

    Google Scholar 

  26. Williams DR, Anthony P, Young RJ, et al. Interpreting hospital admissions data across the Komer divide: the example of diabetes in the North Western Region. Diabet Med 1994; 11 (2): 166–9

    Article  PubMed  CAS  Google Scholar 

  27. Dorman JS, LaPorte RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Diabetes 1984; 33: 271–6

    Article  PubMed  CAS  Google Scholar 

  28. Goodkin G. Mortality factors in diabetes. J Occup Med 1975; 17: 716–21

    PubMed  CAS  Google Scholar 

  29. Kostraba IN, Dorman JS, LaPorte RE, et al. The investigation of age at onset as a risk factor for mortality in persons with insulin-dependent diabetes mellitus using Cox proportional hazards models. Am J Epidemiol 1991; 133: 67–72

    PubMed  CAS  Google Scholar 

  30. Olsson J, Persson U, Tollin C, et al. Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care 1994; 17: 1257–63

    Article  PubMed  CAS  Google Scholar 

  31. Pracon Incorporated Center for Economic Studies of Medicine. Direct and indirect costs of diabetes in the United States in 1987. Alexandria (VA): American Diabetes Association, 1988

    Google Scholar 

  32. McKendry JBR. Direct costs of diabetes care: a survey in Ottawa, Ontario 1986. Can J Public Health 1989; 80: 124–9

    PubMed  CAS  Google Scholar 

  33. Olivera EM, Duhalde EP, Gagliardino JJ. Costs of temporary and permanent disability induced by diabetes. Diabetes Care 1991; 14: 593–6

    Article  PubMed  CAS  Google Scholar 

  34. The Carter Center of Emory University. Closing the gap: the problem of diabetes mellitus in the United States. Diabetes Care 1985; 8: 391–406

    Article  Google Scholar 

  35. Kovar MG, Harris ML, Hadden WC. The scope of diabetes in the United States population. Am J Public Health 1987; 77:1549–50

    Article  PubMed  CAS  Google Scholar 

  36. Herman WH, Sinnock P, Brenner E, et al. An epidemiologic model for diabetes mellitus: incidence, prevalence, and mortality. Diabetes Care 1984; 7: 367–71

    Article  PubMed  CAS  Google Scholar 

  37. Giordano B, Rosenbloom AL, Heller D, et al. Regional services for children and youths with diabetes. Pediatrics 1977; 60: 492–8

    Google Scholar 

  38. Sutton DL, Greenacre P, Howard NJ, et al. Patterns of hospitalisation in a paediatric diabetes clinic in Sydney. Diabetes Res Clin Pract 1989; 7: 271–6

    Article  PubMed  CAS  Google Scholar 

  39. Spaulding RH, Spaulding WB. The diabetic day-care unit: II. Comparison of patients and costs of initiating insulin therapy in the unit and a hospital. Can Med Assoc J 1976; 114: 780–7

    PubMed  CAS  Google Scholar 

  40. Churchill DN, Lemon BC, Torrance GW. A cost-effectiveness analysis of continuous ambulatory peritoneal dialysis and hospital hemodialysis. Med Decis Making 1984; 4: 489–500

    Article  Google Scholar 

  41. Narins BE, Narins RG. Clinical features and health-care costs of diabetic nephropathy. Diabetes Care 1988; 11: 833–9

    Article  PubMed  CAS  Google Scholar 

  42. Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type 1 diabetes mellitus. Ophthalmology 1991; 98: 1565–74

    PubMed  CAS  Google Scholar 

  43. Lairson DR, Pugh JA, Kapadia AS, et al. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 1992; 15: 1369–77

    Article  PubMed  CAS  Google Scholar 

  44. Singer DE, Nathan DM, Fogel HA, et al. Screening for diabetic retinopathy. Ann Intern Med 1992; 116: 660–71

    PubMed  CAS  Google Scholar 

  45. Borch-Johnsen K, Wenzel H, Viberti GC, et al. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993; 306: 1722–6

    Article  PubMed  CAS  Google Scholar 

  46. Chukwuma C. Type 1 diabetic nephropathy: clinical characteristics and economic impact. J Diabetes Complications 1993; 7: 15–27

    Article  PubMed  Google Scholar 

  47. Leese GP, Ahmed S, Newton RW, et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ 1993; 306: 187–9

    Article  PubMed  CAS  Google Scholar 

  48. Simell T. Cost-effectiveness analysis of short-term and long-term initial hospital stay of children with insulin-dependent diabetes mellitus. Publications of the Social Insurance Institution, Finland 1994; ML 128: 15

  49. Hürter P. Hospital and long-term care of diabetic children and adolescents and their parents [in German]. Monatsschr Kinderheilkd 1984; 132: 635–9

    PubMed  Google Scholar 

  50. Mullis P, Vökle H, Sigrist V, et al. Comparison of fructosamine and glycated haemoglobin in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 351–4

    Article  PubMed  CAS  Google Scholar 

  51. Schneider AJ. Starting insulin therapy in children with newly diagnosed diabetes. Am J Dis Child 1983; 137: 782–6

    PubMed  CAS  Google Scholar 

  52. Hamman RE, Cook M, Keefer S, et al. Medical care patterns at the onset of insulin-dependent diabetes mellitus: association with severity and subsequent complications. Diabetes Care 1985; 8 Suppl. 1: 94–100

    PubMed  Google Scholar 

  53. Sperling MA. Outpatient management of diabetes mellitus. Pediatr Clin North Am 1987; 34: 919–34

    PubMed  CAS  Google Scholar 

  54. Delamater AM, Bubb J, Davis SG, et al. Randomized prospective study of self-management training with newly diagnosed diabetic children. Diabetes Care 1990; 13: 492–8

    Article  PubMed  CAS  Google Scholar 

  55. Laron Z, Galatzer A, Amir S, et al. A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care 1979; 2: 342–8

    Article  PubMed  CAS  Google Scholar 

  56. Duncan JA, Malone JI. An out-of-hospital approach to the newly diagnosed diabetic. Con temp Pediatr 1986; 3: 79–86

    Google Scholar 

  57. de Weerdt I, Visser AP, Kok GJ, et al. Randomized controlled multicentre evaluation of an education programme for insulin- treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med 1991; 8: 338–45

    Article  PubMed  Google Scholar 

  58. National Board of Health in Finland. The top 50 of pediatric diseases in 1985. Helsinki: National Board of Health in Finland, 1987

    Google Scholar 

  59. Bruce DG, Clark EM, Danesi GA, et al. Outpatient initiation of insulin therapy in patients with diabetes mellitus. Med J Aust 1987; 146: 19–22

    PubMed  CAS  Google Scholar 

  60. Martin S, Pawlowski B, Greulich B, et al. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care 1992; 15: 66–74

    Article  PubMed  CAS  Google Scholar 

  61. Schiffrin A, Suissa S, Weitzner G, et al. Factors predicting course of β-cell function in IDDM. Diabetes Care 1992; 15: 997–1001

    Article  PubMed  CAS  Google Scholar 

  62. Yki-Järvinen H, Koivisto VA. Natural course of insulin resistance in type 1 diabetes. N Engl J Med 1986; 315: 224–30

    Article  PubMed  Google Scholar 

  63. Egger M, Gschwend S, Smith GD, et al. Increasing incidence of hypoglycemic coma in children with IDDM. Diabetes Care 1991; 14: 1001–5

    Article  PubMed  CAS  Google Scholar 

  64. Simell T, Kaprio EA, Mäenpää J, et al. Randomised prospective study of short-term and long-term initial hospital stay by children with diabetes mellitus. Lancet 1991; 337: 656–60

    Article  PubMed  CAS  Google Scholar 

  65. Kangas T, Koivisto VA, Reunanen A, et al. Mode of treatment, structure and direct costs of diabetes care in Finland [abstract no. 08A5PP0133]. Abstracts of the Fifteenth International Diabetes Federation Congress; 1994 Nov 6–11: Kobe (Japan)

  66. Muhlhauser I, Berger M, Sonnenberg D, et al. Incidence and management of severe hypoglycemia in 434 adults with insulin- dependent diabetes mellitus. Diabetes Care 1985; 8: 274–8

    Article  Google Scholar 

  67. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90: 450–9

    Google Scholar 

  68. Orchard TJ, Maser RE, Becker DJ, et al. Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med 1991; 8: 469–74

    Article  PubMed  CAS  Google Scholar 

  69. Reichard P, Pihl M. Mortality and treatment side-effects during long term intensified conventional insulin treatment in the Stockholm diabetes intervention study. Diabetes 1994; 43: 313–7

    Article  PubMed  CAS  Google Scholar 

  70. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697–703

    Article  PubMed  CAS  Google Scholar 

  71. Egger M, Smith GD, Imhoof H, et al. Risk of severe hypoglycaemia in insulin treated diabetic patients transferred to human insulin: a case control study. BMJ 1991; 303: 617–21

    Article  PubMed  CAS  Google Scholar 

  72. Vijayalakshmi B, Wolfsdorf JI. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics 1991; 88: 1187–93

    Google Scholar 

  73. MacFarlane PI, Smith CS. Perceptions of hypoglycemia in childhood diabetes mellitus: a questionnaire study. Pract Diabetes 1988; 5: 56–8

    Article  Google Scholar 

  74. Geiss LS, Herman WH, Goldschmid MG, et al. Surveillance for diabetes mellitus — United States, 1980–1989. MMWR CDC Surveill Summ 1993 Jun 4; 42: 1–20

    Google Scholar 

  75. Stephenson J, Fuller JH. Eurodiab IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the Eurodiab IDDM Complications Study. Diabetologia 1994; 37: 278–85

    Article  Google Scholar 

  76. Lounamaa R. Mortality in Finnish patients with insulin-dependent diabetes mellitus: a follow-up study of patients diagnosed when under twenty years of age. Publications of the Social Insurance Institution, Finland. ML 126. Helsinki: Social Insurance Institution, Finland, 1993

  77. The Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment: follow-up of the Kroc Collaborative Study. JAMA 1988; 260: 37–41

    Article  Google Scholar 

  78. Feldt-Rasmussen B, Mathiesen ER, Jensen T, et al. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164–70

    Article  PubMed  CAS  Google Scholar 

  79. Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, et al. Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 1992; 304: 19–22

    Article  PubMed  CAS  Google Scholar 

  80. Kullberg CE, Arnqvist HJ. Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients. Diabetologia 1993; 36: 961–5

    Article  PubMed  CAS  Google Scholar 

  81. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304–9

    Article  PubMed  CAS  Google Scholar 

  82. Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 1309–14

    Article  PubMed  CAS  Google Scholar 

  83. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993; 329: 977–86

    Article  Google Scholar 

  84. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306–9

    Article  PubMed  CAS  Google Scholar 

  85. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527–32

    Article  PubMed  CAS  Google Scholar 

  86. Stewart LL, Field LL, Ross S, et al. Genetic risk factors in diabetic retinopathy. Diabetologia 1993; 36: 1293–8

    Article  PubMed  CAS  Google Scholar 

  87. Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group, editor. Diabetes in America: diabetes data compiled 1984. Bethesda (MD): US Department of Health and Human Services (NIH Publ. No. 85–1468). Public Health Service, NIH, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, 1985: Chapter XIII: 1–36

  88. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics. Ophthalmology 1989; 96: 255–64

    PubMed  CAS  Google Scholar 

  89. Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care 1994; 17:909–17

    Article  PubMed  CAS  Google Scholar 

  90. Damsgaard EMS. Known diabetes and fasting hyperglycemia in the elderly: prevalence and economic impact upon health services. Dan Med Bull 1990; 37: 530–46

    PubMed  CAS  Google Scholar 

  91. Reddi AS, Camerini-Davalos RA. Diabetic nephropathy - an update. Arch Intern Med 1990; 150: 31–43

    Article  PubMed  CAS  Google Scholar 

  92. Herman WH, Teutsch SM. Chapter XIV: kidney diseases associated with diabetes. In: Harris MI, Hamman RF, editors. Diabetes in America: diabetes data compiled 1984. Bethesda (MD): US Department of Health and Human Services Publ. No. 85–1468,1985 Aug: 1–31

    Google Scholar 

  93. US Renal Data System. 1989 annual data report. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 1989

    Google Scholar 

  94. Jones SL, Viberti GC. Hypertension and microalbuminuria as predictors of diabetic nephropathy. Diabete Metab 1989; 15: 327–32

    PubMed  CAS  Google Scholar 

  95. Shapiro FL, Comty CM. Hemodialysis in diabetics — 1979 update. In: L’Esperance FA, editor. The diabetic renal syndrome. New York: Grune and Stratton, 1980: 333–43

    Google Scholar 

  96. Shyh TF, Bayer M. Treatment of uremic diabetic. Nephron 1985; 40: 129–38

    Article  PubMed  CAS  Google Scholar 

  97. Grenfell A, Watkins PJ. Clinical diabetic nephropathy: natural history and complications. Clin Endocrinol Metab 1986; 15: 783–805

    Article  PubMed  CAS  Google Scholar 

  98. Matsushima M, Tajima N, LaPorte RE, et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) US-Japan Mortality Study Group. Diabetologia 1995; 38: 236–43

    Article  PubMed  CAS  Google Scholar 

  99. Borch-Johnsen K, Nissen H, Henriksen E, et al. The natural history of insulin dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med 1987; 4: 201–10

    Article  PubMed  CAS  Google Scholar 

  100. Królewski AS, Warram JH, Rand Ll, et al. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390–8

    Article  PubMed  Google Scholar 

  101. Geiss LS, Herman WH, Teutsch SM. Diabetes and renal mortality in the United States. Am J Public Health 1985; 79: 1325–6

    Article  Google Scholar 

  102. Eggers PW. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988; 381: 223–9

    Article  Google Scholar 

  103. Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care 1995; 18: 1383–94

    PubMed  CAS  Google Scholar 

  104. Knulman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 36: 1332–9

    Article  Google Scholar 

  105. Criado E, De Stefano AA, Keagy BA, et al. The course of severe foot infection in patients with diabetes. Surg Gynecol Obstet 1992; 175: 135–40

    PubMed  CAS  Google Scholar 

  106. Apelqvist J, Ragnarson-Tennvall G, Persson U, et al. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463–71

    Article  PubMed  CAS  Google Scholar 

  107. Bild DE, Selby JV, Sinnock P, et al. Lower-extremity amputations in people with diabetes. Diabetes Care 1989; 12: 24–30

    Article  PubMed  CAS  Google Scholar 

  108. Fylling CP, Knighton DR. Amputation in the diabetic population: incidence, causes, cost, treatment and prevention. J Enterostom Ther 1989; 16: 247–55

    CAS  Google Scholar 

  109. Earle K, Walker J, Hill C, et al. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes nephropathy. N Engl J Med 1992; 326: 673–7

    Article  PubMed  CAS  Google Scholar 

  110. Norgaard K, Methiesen ER, Hommel E, et al. Lack of familial predisposition to cardiovascular disease in type 1 (insulindependent) diabetic patients with nephropathy. Diabetologia 1991; 34: 370–2

    Article  PubMed  CAS  Google Scholar 

  111. Mogensen CE. Antihypertensive treatment inhibiting the progression of diabetic nephropathy. Acta Endocrinol 1980; 94 Suppl. 238: 103–11

    Google Scholar 

  112. Parving HH, Andersen AR, Smidt UM, et al. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175–9

    Article  PubMed  CAS  Google Scholar 

  113. Lithner F. Epidemiology and economic impact of the diabetic foot — a major health care problem. In: Bakker K, Niewenhuijzen Kruseman AC, editors. The diabetic foot. Amsterdam: Excerpta Medica, 1991: 9–17

    Google Scholar 

  114. Jackson RL. Growth and maturation of children with insulin-dependent diabetes mellitus. Pediatr Clin North Am 1984; 3.1: 545–67

    Google Scholar 

  115. Leslie ND, Sperling MA. Relation of metabolic control to complications in diabetes mellitus. J Pediatr 1986; 108: 491–7

    Article  PubMed  CAS  Google Scholar 

  116. Miihlhauser I, Berger M. Diabetes education and insulin therapy: when will they ever learn? J Intern Med 1993; 233: 321–6

    Article  Google Scholar 

  117. Kirschenbaum DM. Glycosylation of proteins: its implications in diabetic control and complications. Pediatr Clin North Am 1984; 31: 611–21

    PubMed  CAS  Google Scholar 

  118. Monnier VM, Vishwanath V, Frank KE, et al. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403–8

    Article  PubMed  CAS  Google Scholar 

  119. Chaturvedi N, Fuller JH, Stevens LK, et al. Mortality and morbidity associated with body weight in people with IDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 1995; 18: 761–5

    Article  PubMed  CAS  Google Scholar 

  120. Elliot RB, Chase H. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991; 34: 362–5

    Article  Google Scholar 

  121. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341: 927–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics and MediCity Research Laboratory, University of Turku, FIN-20520, Turku, Finland

    Tuula T. Simell, Jarmo Hahl & Olli C. Simell

  2. Department of Health Services Administration, University of Kuopio, Kuopio, Finland

    Harri Sintonen

Authors
  1. Tuula T. Simell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harri Sintonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jarmo Hahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olli C. Simell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simell, T.T., Sintonen, H., Hahl, J. et al. Costs of Insulin-Dependent Diabetes Mellitus. Pharmacoeconomics 9, 24–38 (1996). https://doi.org/10.2165/00019053-199609010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199609010-00004

Keywords

Search

Navigation